BIOFRONTERA INC (BFRI) Stock Income Statement
NASDAQ:BFRI - Nasdaq - US09077D2099 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 38.00M | 37.32M | 34.07M | 28.67M | 24.10M | |||
| Cost Of Goods | 17.76M | 18.61M | 17.44M | 15.19M | 12.74M | |||
| Gross Profit | 20.24M | 18.71M | 16.63M | 13.49M | 11.36M | |||
| Operating Expenses | 36.53M | 35.92M | 38.00M | 31.20M | 24.56M | |||
| Research and Development | 3.28M | 2.09M | N/A | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 33.24M | 33.84M | 37.80M | 34.90M | 25.84M | |||
| Operating Income | -16.29M | -17.21M | -21.38M | -17.71M | -13.20M | |||
| Interest Income/Expense | -752.00K | -2.05M | -7.89M | 1.55M | -340.00K | |||
| Other Income/Expense | 5.54M | 1.84M | 3.06M | 16.42M | -12.11M | |||
| Non Recurring Items | 0.00 | -316.00K | 6.08M | -870.00K | -12.00M | |||
| Income Before Taxes | -11.51M | -17.74M | -20.12M | -610.00K | -37.66M | |||
| Income Tax | 19.00K | 22.00K | 14.00K | 30.00K | 60.00K | |||
| Net Income | -11.53M | -17.76M | -20.13M | -640.00K | -37.71M | |||
| EBITDA | -15.97M | -16.79M | -20.87M | -17.19M | -12.66M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.69 | -3.22 | -13.02 | -0.61 | -85.70 | |||
| Non GAAP EPS | -1.75 | -4.16 | -19.27 | -9.60 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 53.26% | 50.14% | 48.80% | 47.05% | 47.14% | |||
| Profit Margin | -30.33% | -47.58% | -59.09% | -2.23% | -156.47% | |||
| Operating Profit Margin | -42.87% | -46.11% | -62.74% | -61.77% | -54.77% | |||
All data in USD